MIF2-IN-1 (compound 5d) is a potent MIF2 tautomerase inhibitor (IC50: 1.0 μM) that inhibits the proliferation of non-small cell lung cancer cells by arresting the cell cycle through the MAPK pathway, with potential applications in cancer disease studies.